Nav: Home

Blood clots may complicate aortic valve replacements

October 05, 2015

LOS ANGELES (Oct. 5, 2015) - Heart valve replacements made from tissue (bioprosthetic valves) have long been thought to be spared the complication of blood clot formation. Researchers have now found that about 15 percent of all bioprosthetic aortic heart valve patients develop blood clots on the leaflets affecting valve opening, regardless of whether the patient received the new valve via open-heart surgery or a minimally-invasive catheter procedure, a new study from the Cedars-Sinai Heart Institute shows.

The study, published online today by the New England Journal of Medicine and scheduled for the Nov. 26 print edition, also shows that anti-coagulant medications such as Warfarin quickly resolve the clotting issue for all patients, regardless of the type of valve or procedure.

Valve replacement is a treatment for aortic stenosis, which is narrowing of the valve between the main pumping chamber of the heart and the aorta, the main artery that carries blood from the heart to the rest of the body. According to the National Institutes of Health, about two percent of people over 65 years of age develop aortic stenosis. Symptoms include chest pain, fatigue, heart palpitations and breathing problems.

"The clinical impact of blood clots on stroke will need to be studied further definitively despite some preliminary signals that clots may predispose to mini strokes," said Raj Makkar, MD, associate director of the Cedars-Sinai Heart Institute, and who is widely regarded as a world leader in performing the minimally invasive heart valve procedures. "Transcatheter and surgically implantable tissue valves are life saving devices in patients with aortic valve stenosis. These findings allow us a potentially valuable opportunity to further optimize the outcomes of these procedures. We are not recommending that all patients with these devices be on blood thinners but clearly further studies need to be done to define best medication regimens."

Said Hasan Jilaihawi, MD, director of Interventional Cardiology Imaging at the Cedars Sinai Heart Institute, "Our study also shows that the novel technique of four-dimensional high resolution CT is superior to routinely used transthoracic cardiac echocardiography for the detection of these valve leaflet clots."

Makkar began the study when a high-resolution imaging study of one of the patients in a clinical trial who had stroke showed clot formation on the aortic valve leaflets that open and close to regulate the flow of blood. "We wanted to find out if patients undergoing a tissue valve procedure are susceptible to blood clots on the leaflets and study the clinical consequences of the same. We also wanted to understand whether our aortic valve patients were more susceptible to having blood clots and whether those clots could indicate that the patient might experience a neurological complication - a mini-stroke," Makkar said.

"This brilliant work highlights a common, previously unsuspected complication of heart valve placement. Such valve replacements are becoming increasingly common as they can now be done with minimally invasive procedures," said Eduardo Marbán, MD, PhD, director of Cedars-Sinai Heart Institute. "Early recognition of clot formation on the valves could save lives and prevent stroke, as those affected could be effectively treated using blood thinners."

The study is the first systematic scientific study using four-dimensional CT angiography to assess valve performance of TAVR and surgical tissue valves in patients with aortic stenosis.

Researchers followed 187 patients who received a new valve by undergoing a transcatheter procedure or open-heart surgery to receive a new valve. All patients in the study had high-resolution imaging so researchers could detect valve problems such as clots and reduced leaflet motion. Findings include:
  • About 15 percent of all valve patients will experience blood clots on the valve's leaflets;

  • In the vast majority of patients, an anti-coagulation medicine like Warfarin, will dissolve the clots;

  • There was some suggestion that the incidence of mini-stroke - called transient ischemic attacks - but not full blown strokes, could be increased by untreated valve leaflet clots but this was inconclusive and requires further study.

The study was supported by grants from St. Jude Medical, which manufactures replacement aortic valves, and the Cedars-Sinai Heart Institute.

About the Cedars-Sinai Heart Institute

The Cedars-Sinai Heart Institute is internationally recognized for outstanding heart care built on decades of innovation and leading-edge research. From cardiac imaging and advanced diagnostics to surgical repair of complex heart problems to the training of the heart specialists of tomorrow and research that is deepening medical knowledge and practice, the Cedars-Sinai Heart Institute is known around the world for excellence and innovations.

Cedars-Sinai Medical Center

Related Stroke Articles:

Retraining the brain to see after stroke
A new study out today in Neurology, provides the first evidence that rigorous visual training restores rudimentary sight in patients who went partially blind after suffering a stroke, while patients who did not train continued to get progressively worse.
Catheter ablations reduce risks of stroke in heart patients with stroke history, study finds
Atrial fibrillation patients with a prior history of stroke who undergo catheter ablation to treat the abnormal heart rhythm lower their long-term risk of a recurrent stroke by 50 percent, according to new research from the Intermountain Medical Center Heart Institute.
Imaging stroke risk in 4-D
A new MRI technique developed at Northwestern University detects blood flow velocity to identify who is most at risk for stroke, so they can be treated accordingly.
Biomarkers may help better predict who will have a stroke
People with high levels of four biomarkers in the blood may be more likely to develop a stroke than people with low levels of the biomarkers, according to a study published in the Aug.
Pre-stroke risk factors influence long-term future stroke, dementia risk
If you had heart disease risk factors, such as high blood pressure, before your first stoke, your risk of suffering subsequent strokes and dementia long after your initial stroke may be higher.
Intervention methods of stroke need to focus on prevention for blacks to reduce stroke mortality
Blacks are four times more likely than their white counterparts to die from stroke at age 45.
Study shows area undamaged by stroke remains so, regardless of time stroke is left untreated
A study led by Achala Vagal, M.D., associate professor at the University of Cincinnati College of Medicine and a UC Health radiologist, looked at a group of untreated acute stroke patients and found that there was no evidence of time dependence on damage outcomes for the penumbra, or tissue that is at risk of progressing to dead tissue but is still salvageable if blood flow is returned in a stroke, but rather an association with collateral flow -- or rerouting of blood through clear vessels.
Immediate aspirin after mini-stroke substantially reduces risk of major stroke
Using aspirin urgently could substantially reduce the risk of major strokes in patients who have minor 'warning' events.
SAGE launches the European Stroke Journal with the European Stroke Organisation
SAGE, a world leading independent and academic publisher, is delighted to announce the launch of the European Stroke Journal, the flagship journal of the European Stroke Organisation.
The S-stroke or I-stroke?
The year 2016 is an Olympic year. Developments in high-performance swimwear for swimming continue to advance, along with other areas of scientific research.

Related Stroke Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...